Home
TARS
TARS News

Latest Tarsus Pharmaceuticals Inc. (TARS) News on February 22, 2025

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

GlobeNewswire

2 days ago

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025

Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

Simply Wall St.

18 days ago

Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

MT Newswires

19 days ago

BofA Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $74

Tarsus to Participate in Upcoming Investor Conferences

GlobeNewswire

23 days ago

Tarsus to Participate in Upcoming Investor Conferences

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

Zacks

a month ago

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

MT Newswires

a month ago

Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $72 From $65, Keeps Outperform Rating

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Insider Monkey

a month ago

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Down -9.11% in 4 Weeks, Here's Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround

Zacks

a month ago

Down -9.11% in 4 Weeks, Here's Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care

GlobeNewswire

a month ago

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care

Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?

Zacks

a month ago

Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?

How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run

Investor's Business Daily

2 months ago

How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run

The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

Zacks

2 months ago

The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

Zacks

2 months ago

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet

Zacks

3 months ago

Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet

Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade

Zacks

3 months ago

Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade

Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

MT Newswires

3 months ago

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $65 From $63, Maintains Outperform Rating

Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

GuruFocus.com

3 months ago

Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates

Zacks

3 months ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates

MT Newswires

3 months ago

Tarsus Pharmaceuticals Q3 Loss Narrows, Revenue Surges

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

GlobeNewswire

3 months ago

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

GlobeNewswire

3 months ago

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

3 months ago

Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

GlobeNewswire

4 months ago

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer

GlobeNewswire

4 months ago

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer

Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains?

Zacks

4 months ago

Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains?

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

Zacks

4 months ago

Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%

GlobeNewswire

4 months ago

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%

Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ...

GuruFocus.com

4 months ago

Tarsus Pharmaceuticals Inc (TARS) Q2 2024 Earnings Call Highlights: Robust Sales Growth and ...

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024

GlobeNewswire

5 months ago

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

GlobeNewswire

6 months ago

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

Need To Know: Analysts Are Much More Bullish On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Revenues

Simply Wall St.

6 months ago

Need To Know: Analysts Are Much More Bullish On Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Revenues

MT Newswires

6 months ago

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $63 From $61, Maintains Outperform Rating

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates

Zacks

6 months ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates

Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

GlobeNewswire

6 months ago

Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

GlobeNewswire

7 months ago

Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?

Simply Wall St.

7 months ago

When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

8 months ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Business Wire

8 months ago

Form 8.3 - Darktrace plc

Business Wire

8 months ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

8 months ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

8 months ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

8 months ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

GlobeNewswire

8 months ago

Middlefield Canadian Income PCC: Net Asset Value(s)

Business Wire

8 months ago

Form 8.3 - International Paper Company

Tarsus to Participate in Upcoming Investor Conferences

GlobeNewswire

9 months ago

Tarsus to Participate in Upcoming Investor Conferences

Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall St.

9 months ago

Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates

Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

GlobeNewswire

9 months ago

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript

MT Newswires

9 months ago

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating

GuruFocus.com

9 months ago

Tarsus Pharmaceuticals Inc (TARS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth ...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates

Zacks

9 months ago

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates

Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements

GlobeNewswire

9 months ago

Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements

Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?

Zacks

10 months ago

Does Tarsus Pharmaceuticals (TARS) Have the Potential to Rally 38.7% as Wall Street Analysts Expect?

Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

GlobeNewswire

10 months ago

Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

GlobeNewswire

10 months ago

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%

Simply Wall St.

10 months ago

Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%

Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know

Zacks

10 months ago

Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know

Aggressive Stock Portfolio: 13 Stocks Picked by Analysts

Insider Monkey

a year ago

Aggressive Stock Portfolio: 13 Stocks Picked by Analysts

Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why

Zacks

a year ago

Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why

How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%

Zacks

a year ago

How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%

Tarsus to Participate at Upcoming Investor Conferences

GlobeNewswire

a year ago

Tarsus to Participate at Upcoming Investor Conferences

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis

GlobeNewswire

a year ago

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Simply Wall St.

a year ago

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Tarsus Announces Pricing of $100.0 Million Public Offering

GlobeNewswire

a year ago

Tarsus Announces Pricing of $100.0 Million Public Offering

Tarsus Announces Proposed $100.0 Million Public Offering

GlobeNewswire

a year ago

Tarsus Announces Proposed $100.0 Million Public Offering

Party Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecasts

Simply Wall St.

a year ago

Party Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecasts

Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy

Zacks

a year ago

Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript

Tarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

a year ago

Tarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Thomson Reuters StreetEvents

a year ago

Q4 2023 Tarsus Pharmaceuticals Inc Earnings Call

Tarsus Pharmaceuticals Inc (TARS) Reports Robust Q4 and Full-Year 2023 Financial Results

GuruFocus.com

a year ago

Tarsus Pharmaceuticals Inc (TARS) Reports Robust Q4 and Full-Year 2023 Financial Results

Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements

GlobeNewswire

a year ago

Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements

Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease

GlobeNewswire

a year ago

Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease

Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024

GlobeNewswire

a year ago

Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024

Lemonade (LMND) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

a year ago

Lemonade (LMND) Stock Drops Despite Market Gains: Important Facts to Note

When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?

Simply Wall St.

a year ago

When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference

GlobeNewswire

a year ago

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference

Tarsus Pharmaceuticals, Inc. (TARS) Moves 8.5% Higher: Will This Strength Last?

Zacks

a year ago

Tarsus Pharmaceuticals, Inc. (TARS) Moves 8.5% Higher: Will This Strength Last?

Why Zim Integrated Shipping Stock Is Cruising Higher Today

Motley Fool

a year ago

Why Zim Integrated Shipping Stock Is Cruising Higher Today

Unpacking Q3 Earnings: USANA (NYSE:USNA) In The Context Of Other Personal Care Stocks

StockStory

a year ago

Unpacking Q3 Earnings: USANA (NYSE:USNA) In The Context Of Other Personal Care Stocks

First Citizens BancShares, Inc. (NASDAQ:FCNCA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

First Citizens BancShares, Inc. (NASDAQ:FCNCA) Q4 2023 Earnings Call Transcript

Preferred Bank (NASDAQ:PFBC) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Preferred Bank (NASDAQ:PFBC) Q4 2023 Earnings Call Transcript

83% of Warren Buffett's $365 Billion Portfolio Is Invested in Just 7 Stocks

Motley Fool

a year ago

83% of Warren Buffett's $365 Billion Portfolio Is Invested in Just 7 Stocks

Reuters

a year ago

GLOBAL MARKETS-Asia stocks eye weekly gain; US inflation data looms

Isabeau Levito edges Amber Glenn in figure skating nationals short program

NBC Sports

a year ago

Isabeau Levito edges Amber Glenn in figure skating nationals short program

Associated Press Finance

a year ago

Taro: Fiscal Q3 Earnings Snapshot

Business Wire

a year ago

Taro Provides Results for December 31, 2023

TechTarget Named a Middle Market Leader by Boston Business Journal for Second Straight Year

Business Wire

a year ago

TechTarget Named a Middle Market Leader by Boston Business Journal for Second Straight Year

Investors Heavily Search Target Corporation (TGT): Here is What You Need to Know

Zacks

a year ago

Investors Heavily Search Target Corporation (TGT): Here is What You Need to Know

Corsair Gaming to Report Q4 2023 Financial Results on February 13

Business Wire

a year ago

Corsair Gaming to Report Q4 2023 Financial Results on February 13

A Look Back at Sit-Down Dining Stocks' Q3 Earnings: The ONE Group (NASDAQ:STKS) Vs The Rest Of The Pack

StockStory

a year ago

A Look Back at Sit-Down Dining Stocks' Q3 Earnings: The ONE Group (NASDAQ:STKS) Vs The Rest Of The Pack

Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?

Benzinga

a year ago

Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?

PRA Group Recognized as River Star Business by Elizabeth River Project

PR Newswire

a year ago

PRA Group Recognized as River Star Business by Elizabeth River Project

Monro Muffler Brake (MNRO) Lags Q3 Earnings and Revenue Estimates

Zacks

a year ago

Monro Muffler Brake (MNRO) Lags Q3 Earnings and Revenue Estimates

Teledyne Technologies (TDY) Surpasses Q4 Earnings Estimates

Zacks

a year ago

Teledyne Technologies (TDY) Surpasses Q4 Earnings Estimates

Monro (NASDAQ:MNRO) Misses Q3 Revenue Estimates

StockStory

a year ago

Monro (NASDAQ:MNRO) Misses Q3 Revenue Estimates

PRA Group Names Keith Warren as New Head of Risk and Compliance

PR Newswire

a year ago

PRA Group Names Keith Warren as New Head of Risk and Compliance

Columbus McKinnon Declares Quarterly Dividend of $0.07 per Share

Business Wire

a year ago

Columbus McKinnon Declares Quarterly Dividend of $0.07 per Share

Share on Social Networks: